Full Press Release Details
Biogen Highlights Multiple Assets and Indications in Lupus.
BIIB
Biogen Highlights Multiple Assets and Indications in Lupus
Key Takeaway: Biogen Highlights Multiple Assets and Indications in Lupus
Price reaction · baseline $139.63 (2025-09-02 close) · hit after-hours · clean, no other BIIB news in the window
day 0 close · peak
+1.4%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+34%
120-day peak, hindsight
Typical move
1.8%
average across 15 past catalysts
Lead asset
Alefacept
Phase 3 · Chronic Plaque Psoriasis